Is European journal of clinical pharmacology SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

3.77

Citation rate 4.02 1,283 total citations

h5-index 36 h5 depth signal

Cited share 78.0% 270 of 346

Total citations 1,283 Citation footprint

Metric signal 3.77 External metric anchor

Self-citation 1.2% 16 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 420

United States 214

France 169

Germany 163

Italy 159

Citing Fields of Research

Pharmacology & Toxicology 553

Cardiology 372

Patient Care 274

Medical Ethics 231

Antibiotic & Antibacterial Agents 147

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 11,057 Articles tracked across the journal lifetime

Indexed publication set 346 270 cited publications

Last 12 months 266 22.2 publications/month

Open access share 28.6% 76 OA publications in the last year

Leading citing country China 420 citing publications

Leading citing field Pharmacology & Toxicology 553 citing publications

Latest tracked publication 21 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v3n4, Sept. 1971-

PubMed

v3n4, Sept. 1971-

Index medicus

Active Coverage

Research Focus & Classification

Indexed Subjects

Cardiology Pharmacology & Toxicology Anesthetic & Pain Medicine Patient Care Medical Ethics Psychiatry

Broad Categories

Drug Therapy Pharmacology Cardiology Medical Ethics Antibiotic & Antibacterial Agents Diabetes Patient Care Urology Transplantation

MeSH Descriptors

Drug Therapy Pharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 21 October 2026

DOI 10.1007/s00228-026-04204-6

Response to the correspondence regarding “Association between anticholinergic and sedative medications and physical functioning: data from the Canadian Longitudinal Study on Aging (CLSA)”

Open DOI

Benoit Cossette, Keren Pelen, Karina Lebel et al.

02 20 October 2026

DOI 10.1007/s00228-026-04201-9

Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials

Open DOI

Abdullah M Alharran, Khaled M Alsaleeli, Ahmed S Alkhamis et al.

03 17 October 2026

DOI 10.1007/s00228-026-04205-5

From historical dosing to precision dosing: Modernising tobramycin monitoring in people with cystic fibrosis

Open DOI

Ellie Johnson, Michael Williams, Daniel Henderson et al.

Background: Historical therapeutic drug monitoring (TDM) strategies for intravenous tobramycin in people with cystic fibrosis (pwCF) were developed in the pre-CFTR modulator era and relied predominantly on clearance-based monitoring to m...

04 14 October 2026

DOI 10.1007/s00228-026-04198-1

What should be updated in the WHO guide to good prescribing?

Open DOI

Mariëlle G. Hartjes, Fleur M.W. Hendriksen, Michiel J. Bakkum et al.

Purpose: Over 30 years ago, the World Health Organization (WHO) published the Guide to Good Prescribing (GGP) with its accompanying six-step model for rational prescribing. While widely used and proven effective in teaching clinical phar...

05 14 October 2026

DOI 10.1007/s00228-026-04196-3